Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced new results from the Phase 3 PALISADE study and the open-label extension from the Phase 2 MUIR and SHASTA-2 studies of investigational ...

Predicting who is at high risk for a heart attack or death may be as simple as obtaining a person's coronary artery calcium ...

Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed ...

A prescription medication that has been available in the U.S. since 1992 might have another significant benefit.

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

Diabetes is a widespread condition that can lead to serious health issues when not managed well. One of the most concerning ...

Plozasiran specifically targets and reduce the production of APOC3, thereby reducing triglyceride levels and lowering the ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

More young people are experiencing strokes and researchers at Cleveland Clinic have published new findings exploring the ...

A health watchdog has stressed that hormone replacement therapy (HRT) should be the first treatment offered to women with ...

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of ...